Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by dt_coreon Apr 06, 2011 10:31am
226 Views
Post# 18392687

Top Holders Update:

Top Holders Update:Some selling from the Top Holders of HEM the past few months. A lot of new buyers though from the US (smaller guys, they don't make the top 10). Overall the ownership is getting less concentrated (a positive).

1. Richard Heiniger 7.7% (unch)
2. Pyramis 4.9% (sold 2.6mm shares in Feb)
3. Petercam 3.5% (unch)
4. Heartland 3.3% (unch)
5. Dimensional 1.8% (bought 10.4K shares)

Front Street is nearly done exiting their position, now holding only 800K shares. Also interesting to note that Mackenzie Financial sold their 1.2mm share holding back in Feb.

Hopefully this means most of the sellers have been shaken out. Also no short interest. Could see the next leg up shortly.


Bullboard Posts